Chang R L, Huang M T, Wood A W, Wong C Q, Newmark H L, Yagi H, Sayer J M, Jerina D M, Conney A H
Carcinogenesis. 1985 Aug;6(8):1127-33. doi: 10.1093/carcin/6.8.1127.
Ellagic acid, quercetin and robinetin were tested for their ability to antagonize the tumor-initiating activity of benzo[a]pyrene (B[a]P) and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (B[a]P 7,8-diol-9,10-epoxide-2), the ultimate carcinogenic metabolite of benzo[a]-pyrene. Ellagic acid, robinetin or quercetin (2500 nmol) had no tumor-initiating activity on mouse skin, but the topical application of 2500 nmol of ellagic acid 5 min before a tumor-initiating dose of 200 nmol of B[a]P 7,8-diol-9,10-epoxide-2 caused a 59-66% inhibition in the number of skin tumors per mouse that were observed after 15-20 weeks of promotion with 12-O-tetradecanoylphorbol-13-acetate. Similar treatment with 2500 nmol of robinetin or quercetin caused a statistically insignificant 16-24% inhibition in the tumor-initiating activity of 200 nmol of B[a]P 7,8-diol-9,10-epoxide-2 applied 5 min later. Treatment of mice with 2500 nmol of ellagic acid 5 min before the application of 50 nmol of B[a]P inhibited the mean number of skin tumors per mouse by 28-33% after 15-20 weeks of promotion, but these decreases were not statistically significant. Robinetin and quercetin had little or no effect on the tumor-initiating activity of B[a]P on mouse skin. Treatment of preweanling mice with 1/7, 2/7 and 4/7 of the total dose of ellagic acid (300 nmol), robinetin (1400 nmol), myricetin (1400 nmol) or quercetin (1400 nmol) i.p. on their first, eighth and fifteenth day of life, respectively, did not cause the formation of tumors in animals that were killed 9-11 months later. Similar treatment of preweanling mice with the above doses of the phenolic compounds 10 min before the i.p. injection of a total dose of 30 nmol of B[a]P 7,8-diol-9,10-epoxide-2 during the animal's first 15 days of life caused a 44-75% inhibition in the number of diol-epoxide-induced pulmonary tumors per mouse. Similar treatment with these plant phenols had little or no effect on B[a]P-induced pulmonary tumors.
对鞣花酸、槲皮素和刺槐素拮抗苯并[a]芘(B[a]P)和(±)-7β,8α-二羟基-9α,10α-环氧-7,8,9,10-四氢苯并[a]芘(B[a]P 7,8-二醇-9,10-环氧化物-2,苯并[a]芘的最终致癌代谢物)的肿瘤启动活性的能力进行了测试。鞣花酸、刺槐素或槲皮素(2500 nmol)对小鼠皮肤没有肿瘤启动活性,但在给予200 nmol B[a]P 7,8-二醇-9,10-环氧化物-2的肿瘤启动剂量前5分钟局部应用2500 nmol鞣花酸,在用12-O-十四烷酰佛波醇-13-乙酸酯促进15 - 20周后,每只小鼠的皮肤肿瘤数量减少了59 - 66%。用2500 nmol刺槐素或槲皮素进行类似处理,对5分钟后应用的200 nmol B[a]P 7,8-二醇-9,10-环氧化物-2的肿瘤启动活性产生了统计学上无显著意义的16 - 24%的抑制。在应用50 nmol B[a]P前5分钟用2500 nmol鞣花酸处理小鼠,在促进15 - 20周后,每只小鼠的皮肤肿瘤平均数量减少了28 - 33%,但这些减少在统计学上不显著。刺槐素和槲皮素对B[a]P在小鼠皮肤上的肿瘤启动活性几乎没有影响。在幼龄小鼠出生后的第一天、第八天和第十五天分别腹腔注射鞣花酸(300 nmol)、刺槐素(1400 nmol)、杨梅素(1400 nmol)或槲皮素(1400 nmol)总剂量的1/7、2/7和4/7,在9 - 11个月后处死动物时未导致肿瘤形成。在幼龄小鼠出生后的前15天,在腹腔注射30 nmol B[a]P 7,8-二醇-9,10-环氧化物-2总剂量前10分钟,用上述剂量的酚类化合物对幼龄小鼠进行类似处理,每只小鼠的二醇环氧化物诱导的肺肿瘤数量减少了44 - 75%。用这些植物酚类进行类似处理对B[a]P诱导的肺肿瘤几乎没有影响。